Effect of Acoramidis on Myocardial Structure and Function in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Cardiac Magnetic Resonance (CMR) Substudy

Affiliations

• ¹ Division of Medicine, National Amyloidosis Centre, University College London, Royal Free Hospital, United Kingdom (Y.R., A.M.-N., A.I., L.V., R.P., J.D.G., M.F.).
• ² Medical University of South Carolina, Charleston (D.P.J.).
• ³ National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (P.K.).
• ⁴ Richmond Pharmacology, London, United Kingdom (L.E., J.T.).
• ⁵ BridgeBio Pharma Inc, San Francisco, CA (J.D., J.-F.T., A.C., S.S., L.K., J.C.F.).